Please login to the form below
Leadiant
This page shows the latest Leadiant news and features for those working in and with pharma, biotech and healthcare.
Leadiant gets FDA OK for bubble boy disease drug
It provides an alternative to Leadiant’s current animal-derived enzyme replacement therapy Adagen (pegademase bovine) which comes from cows. ... News of the approval is a boost to Leadiant, which is currently facing fierce criticism over alleged
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest from PMHub
-
Say Communications
Leadiant Biosciences. MDNA Life Sciences. Meningitis Research Foundation. MZP Tech. Natia Care.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Eli Lilly begins COVID-19 prevention trial in nursing homes
- New study identifies drugs that are safe to use in COVID-19 treatment
- Biogen pays Denali $1bn upfront for Parkinson’s disease programme
- Tecentriq combo fails in advanced triple negative breast cancer
- Bristol-Myers Squibb’s revenues rise on Celgene acquisition
- Novartis builds its case for novel MS treatment ofatumumab
- Virtual Hackathon on Healthcare Innovation: a Customer Story
- OPEN Health at the World Orphan Drug Conference USA
- US pays $1.5bn for 100 million doses of Moderna’s COVID-19 vaccine
- Vir Biotech plans to start mid-to-late stage study of COVID-19 antibody this month
- Russia becomes first country to approve a COVID-19 vaccine
- Can involving patients in design transform the clinical trial experience?
PMHub
Iguazu
Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...
Latest intelligence
- Virtual Hackathon on Healthcare Innovation: a Customer Story
- How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
- OPEN Health at the World Orphan Drug Conference USA
- Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...
- Can involving patients in design transform the clinical trial experience?
- While the research space is a heavily regulated environment and there are rules that we must abide by, this doesn’t mean clinical study materials have to be ‘boring’ or the...
Quick links
Infographics
